In the News

Newer glucose-lowering drugs associated with lower mortality risk than insulin

Researchers compared Swedish patients with type 2 diabetes who were new users of dipeptidyl peptidase-4 inhibitors or sodium-glucose cotransporter-2 inhibitors with patients initiating insulin.

Approved drugs for diabetic neuropathy better than placebo, review finds

In addition to approved drugs duloxetine, pregabalin, and tapentadol, some benefits were found with venlafaxine, oxcarbazepine, tricyclic antidepressants, tramadol, and botulinum toxin.

Insulin pump didn't improve glycemic control compared to training on injections

British patients with type 1 diabetes were enrolled in group training courses that taught flexible intensive insulin treatment and then randomized to an insulin pump or multiple daily injections and followed for two years.

MKSAP quiz: Carotid artery stenosis and diabetes

This month's quiz asks readers to evaluate a 57-year-old man with coronary artery disease, type 2 diabetes, and a mixed density plaque at the origin of the left internal carotid artery.

Spotlight on diabetes incidence and complications

Mortality and cardiovascular complications from diabetes have gone down, but incidence rates among youth are up, according to recent studies of Swedish and American patients, respectively.

Guideline: The USPSTF recommends low- to moderate-dose statins to prevent CVD in selected adults 40 to 75 years of age

The U.S. Preventive Services Task Force (USPSTF) issued a recommendation on use of statins for primary prevention of cardiovascular disease (CVD).

Virtual glucose monitoring service may improve inpatient glycemic control

The service used the electronic health record to send daily reports on inpatients with abnormal glucose values or insulin pump use to experienced diabetes clinicians who could remotely enter a glucose management note with insulin recommendations.